| Id Consultants Of Northeast Ohio, Inc | |
|
3609 Park East Dr Ste 207 Beachwood OH 44122-4309 | |
| (216) 360-0456 | |
| (216) 360-9449 |
| Full Name | Id Consultants Of Northeast Ohio, Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 3609 Park East Dr Ste 207, Beachwood, Ohio |
| Authorized Official Name and Position | Vimala Shakar (ADMIN) |
| Authorized Official Contact | 2167026600 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Id Consultants Of Northeast Ohio, Inc 3609 Park East Dr Ste 207 Beachwood OH 44122-4309 Ph: (216) 360-9480 | Id Consultants Of Northeast Ohio, Inc 3609 Park East Dr Ste 207 Beachwood OH 44122-4309 Ph: (216) 360-0456 |
| NPI Number | 1255913117 |
|---|---|
| Provider Enumeration Date | 04/21/2021 |
| Last Update Date | 04/21/2021 |
| Medicare PECOS PAC ID | 1355747882 |
|---|---|
| Medicare Enrollment ID | O20210909001394 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255913117 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | (* (Not Available)) | Primary |
| Provider Name | K V Gopalakrishna |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1295769735 PECOS PAC ID: 4385622851 Enrollment ID: I20040717000302 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Richard A Chmielewski |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1174557615 PECOS PAC ID: 7012996598 Enrollment ID: I20040717000406 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | David M Hutt |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1992739445 PECOS PAC ID: 9830178318 Enrollment ID: I20040717000408 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Eva Ann Szathmary |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1750311544 PECOS PAC ID: 9739168212 Enrollment ID: I20040717000418 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Najma Abdul Razzak |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1841227063 PECOS PAC ID: 3173597648 Enrollment ID: I20040820000756 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Matthew Schinabeck |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1285662346 PECOS PAC ID: 8729047618 Enrollment ID: I20041006001040 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Houssein D Jahamy |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1982730578 PECOS PAC ID: 3971603689 Enrollment ID: I20070711000086 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | David B Blossom |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1255501557 PECOS PAC ID: 3375614043 Enrollment ID: I20080624000471 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | William John Riebel |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1942213277 PECOS PAC ID: 8224153945 Enrollment ID: I20100917000178 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Zhuolin Han |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1811034622 PECOS PAC ID: 0042489122 Enrollment ID: I20110805000423 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Linda M Ward |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104253665 PECOS PAC ID: 7810125671 Enrollment ID: I20140124001221 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Sachin V Patel |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1942592258 PECOS PAC ID: 3577864941 Enrollment ID: I20161109001725 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Tannaz Asadi |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1790122893 PECOS PAC ID: 3577826924 Enrollment ID: I20180417001612 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Rishi Sharma |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1225472376 PECOS PAC ID: 7517260276 Enrollment ID: I20180604002901 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Hilary Steele |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1912342106 PECOS PAC ID: 6204060494 Enrollment ID: I20180710002990 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Christina Dibartolomeo Boswell |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1972031037 PECOS PAC ID: 2365798527 Enrollment ID: I20190725003519 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Muhannad Tello |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1902118136 PECOS PAC ID: 7012145501 Enrollment ID: I20200514000398 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
| Provider Name | Kaitlyn E Weinert-stein |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1710482062 PECOS PAC ID: 2860748811 Enrollment ID: I20230718003916 |
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
News Archive
Oral health is often the window to your overall health. Evidence has supported the link between poor oral health and such conditions as stroke, premature birth and diabetes. Other conditions, such as HIV/AIDS and osteoporosis may show preliminary signs in your mouth, before other areas of the body are affected. Also, some of your daily activities or habits can affect your oral health. Therefore, it's wise to pay attention to your teeth and gums.
Disadvantaged, unhealthy mothers are much more likely to have sickly children than are disadvantaged moms who are relatively healthy—and this is not only due to genetics, suggests new research to be presented at the 106th Annual Meeting of the American Sociological Association.
Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced acquisition of superDimension, Ltd., for an aggregate consideration of approximately $300 million, with future earn out payments possible.
Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, an Israeli Biopharmaceutical company, announced today the initiation of preparatory work for a Phase III trial with CF101 in Psoriasis. This is based on the successful conclusion of a Phase II dose-response clinical study with CF101 to treat patients with moderate to severe Psoriasis; the study successfully met its primary objective of efficacy and safety
Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.
› Verified 9 days ago
American Medical Legal Consultants Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 25450 Twickenham Dr, Beachwood, OH 44122 Phone: 216-464-5880 | |
Fatuma Midamba Md Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3619 Park East Dr, 205 S, Beachwood, OH 44122 Phone: 216-591-0942 Fax: 440-834-1902 | |
Everside Health, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 25700 Science Park Dr Ste 120, Beachwood, OH 44122 Phone: 216-672-0211 | |
Impact Physician Group, Ohio Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23333 Harvard Rd, Beachwood, OH 44122 Phone: 216-593-2200 | |
Uhmp - Centers For Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3909 Orange Pl Ste 2500, Beachwood, OH 44122 Phone: 216-383-6776 Fax: 216-383-6745 | |
Connections Health Wellness Advocacy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 24200 Chagrin Blvd, Beachwood, OH 44122 Phone: 216-831-6466 Fax: 216-766-6083 | |
Id Consultants, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3609 Park East Dr, 207, Beachwood, OH 44122 Phone: 216-360-0456 Fax: 216-360-9449 |